Tempest Therapeutics Inc (TPST) has gained Tuesday morning, with the stock climbing 1.85% in pre-market trading to 3.85. TPST's short-term technical score of 87 indicates that the stock has traded more bullishly over the last month than 87% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, Tempest Therapeutics Inc ranks higher than 94% of stocks. Tempest Therapeutics Inc has fallen 18.88% over the past month, closing at $4.15 on October 24. During this period of time, the stock fell as low as $2.82 and as high as $5.20. TPST has an average analyst recommendation of Strong Buy. The company has an average price target of $21.67.
TPST has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on TPST!